Leases (Tables) - Sonnet BioTherapeutics Holdings, Inc. [Member] |
12 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2024 | |||||||||||||||||||||||||||||||||||||
| Schedule of Lease Expenses | The components of lease expense for the years ended September 30, 2024 and 2023 are as follows:
|
||||||||||||||||||||||||||||||||||||
| Schedule of Operating Lease Liabilities | Cash flow information related to operating leases for the years ended September 30, 2024 and 2023 is as follows:
|
||||||||||||||||||||||||||||||||||||
| Schedule of Future Minimum Lease Payments | Future minimum lease payments under non-cancellable leases at September 30, 2024 are as follows:
|
||||||||||||||||||||||||||||||||||||